OriGene社 Hypoxia researchers win the 2019 Nobel Prize in medicine
Hypoxia inducible factors (HIF)
- Scientists have won a 2019 Nobel Prize for the study of HIF
This Monday, three scientists have been awarded the Nobel Prize in Medicine for their work on the molecular switch that regulates cell response to oxygen level. The discovery of the central protein, HIF, has led to potential drug development for the treatment of anemia, cancer, and many other diseases.
OriGene offers high quality research products for various HIF subunits, their regulators and downstream target proteins.
HIF subunits
HIF1A Master regulator of hypoxia
HIF2A Share high homology with HIF1A
HIF3A Negative regulator on HIF1A or HIF2A
HIF1B Forms heterodimer with HIF1A and HIF2A
HIF regulators
HIF target genes
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。